Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Cancer Research and Treatment|January 18, 2022
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial StudyJoonha Kwon, Jun Hyeong Lee, Young Han Lee, et al.Oncotarget|October 6, 2017
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancerJi Soo Park, Jong-Chan Youn, Chi Young Shim, et al.Cancer Medicine|October 25, 2021
Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancerTorben Steiniche, Sun Young Rha, Hyun Cheol Chung, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2013
Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumorsHan Sang Kim, Sang Joon Shin, Sang Cheol Kim, et al.Oncotarget|January 27, 2016
Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascitesByungho Lim, Chan Kim, Jeong-Hwan Kim, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancerChang Gon Kim, Moonki Hong, Hei-Cheul Jeung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyChoong-Kun Lee, Hyo Song Kim, Minkyu Jung, et al.Cancers|May 14, 2022
Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and DoxorubicinSeon-Hwa Lee, Iksung Cho, Seng-Chan You, et al.Lung Cancer (Amsterdam, Netherlands)|March 31, 2015
The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancerJi Soo Park, Jae-Seok Lee, Eun Young Kim, et al.Cancer Research and Treatment|October 5, 2018
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical TrialMin Hwan Kim, Xianglan Zhang, Minkyu Jung, et al.Pageof 13